About
Who We Are
Management Team
Scientific Advisors
Board of Directors
Pipeline & Research
Pipeline
Plinabulin
Protein Degradation
Other Pipeline
Posters & Publications
Collaborations
Expanded Access Policy
NEWS & MEDIA
Investors
Stock Overview
Events & Presentations
Financials & Filings
Corporate Governance
Careers
Contact Us
Select Page
BeyondSpring Inc. Data Call
September 21, 2021
09.20.2021
BeyondSpring Inc. Data Call
View webcast
Search for:
RECENT NEWS ARTICLES
BeyondSpring Announces Three Poster Presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting
BeyondSpring Files 2021 Annual Report on Form 20-F
BeyondSpring Announces Fourth Quarter and Year End 2021 Financial Results and Provides a Corporate Update
BeyondSpring to Announce Fourth Quarter and Year End 2021 Financial Results and Host a Conference Call on Thursday, April 14, 2022
BeyondSpring Announces Organizational Streamlining
BeyondSpring Announces Third Quarter 2021 Financial Results and Provides a Corporate Update
BeyondSpring Pharmaceuticals Announces New Clinical Data Confirming Plinabulin’s Fast Onset Mechanism of Action in the Prevention of Chemotherapy-Induced Neutropenia at the 63rd ASH Annual Meeting and Exposition
BeyondSpring Pharmaceuticals Announces Analysis of New Data on the Plinabulin/Pegfilgrastim Combination in Breast Cancer at the 2021 San Antonio Breast Cancer Symposium
BeyondSpring Pharmaceuticals Receives Complete Response Letter from the FDA for Plinabulin New Drug Application for Prevention of Chemotherapy-Induced Neutropenia (CIN)
BeyondSpring Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Conference
RECENT MEDIA COVERAGE
TD Ameritrade Watch List
Managing Chemotherapy Toxicities for Improved Patient Outcomes
New Treatment Modalities: Protein Degraders And Molecular Glues Gain Traction
Seed Therapeutics blossoms in an $800M deal with Lilly
Seed Therapeutics Launches Protein Degradation Research Platform and Appoints Edward Dongheng Liu as Chief Financial Officer
BeyondSpring Forms Partnership Advisory Committee Comprised of Industry Veterans
JAMA Oncology Highlights Plinabulin’s Efficacy in Preventing Chemotherapy-Induced Neutropenia as a Monotherapy
Pegfilgrastim Plus Plinabulin Reduces Chemo-Induced Neutropenia in TAC-Treated Patients
Dr. Lan Huang Featured in Nature Titled “‘Innovation’ Nation”
Woman of the Week Podcast: Dr. Lan Huang, Co-founder, Chairman and Chief Executive Officer BeyondSpring
We use cookies to ensure that we give you the best experience on our website. Please click “OK” to continue or read our Privacy & Cookie Policy.
Ok
Privacy policy
